BIOXBioceres Crop Solutions Corp.(BIOX)Stock Analysis

AI analysis on 2,800+ stocks →
MaterialsNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1769484BIOX stock profile & AI dashboard →

13F Pro Quality Score

20.1/100

Rank #2,679 of 2,879 stocks

View Materials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

7.5/100

Profitability

9.2/100

Balance Sheet

9.3/100

Earnings Quality

30.0/100

Free Cash Flow

30.0/100

Institutional Flow

1.2/100

Revenue Scale

30.1/100

Dilution Risk

94.9/100

BIOX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Bioceres Crop Solutions Corp. (BIOX), a Materials sector company. 13F Pro's AI-powered ranking engine scores BIOX at 20.1/100 on a 32-signal composite quality model, placing it at rank #2,679 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (1.2) and revenue growth (7.5), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Bioceres Crop Solutions Corp. reports quarterly revenue of $65.3M, net income of $-182.5M. Top institutional holders of BIOX by reported 13-F value include Solel Partners, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd., Long Focus Capital Management,, based on the most recent SEC filings. BIOX trades on the Nasdaq exchange and files with the SEC under CIK 1769484. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BIOX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bioceres Crop Solutions Corp. directly from SEC EDGAR. Bioceres Crop Solutions Corp.'s 13F Pro composite quality score has ranged between 20 and 54 since 2023, currently 20.1 — a declining long-term trajectory across 17 quarterly and live scoring snapshots.

Revenue

Q2 2026

$65.3M

Net Income

Q2 2026

$-182.5M

Get alerted when BIOX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Bioceres Crop Solutions Corp. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of BIOX

Put BIOX on your watchlist

Track score changes the day Bioceres Crop Solutions Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is BIOX a good stock to buy?

13F Pro's AI-powered analysis of Bioceres Crop Solutions Corp. (BIOX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BIOX are available on the BIOX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own BIOX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BIOX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bioceres Crop Solutions Corp.'s investment landscape.